A MULTICENTER, SINGLEARM PROSPECTIVE PHASE 3 STUDY TO EVALUATE SAFETY AND EFFICACY OF GLECAPREVIR/ PIBRENTASVIR 8-WEEK TREATMENT IN ADULTS WITH ACUTE HEPATITIS C VIRUS INFECTION
Por:
Llibre, JM, Lank, P, Miller, M, Fredrick, L, Welhaven, A, Semizarov, D, Marcinak, J, Gordon, S, Moon, J, Baumgarten, A and Workowski, K
Publicada:
1 feb 2025
Resumen:
Filiaciones:
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Lank, P:
AbbVie Inc, N Chicago, IL USA
Miller, M:
AbbVie Inc, N Chicago, IL USA
Fredrick, L:
AbbVie Inc, N Chicago, IL USA
Welhaven, A:
AbbVie Inc, N Chicago, IL USA
Semizarov, D:
AbbVie Inc, N Chicago, IL USA
Marcinak, J:
AbbVie Inc, N Chicago, IL USA
Gordon, S:
Henry Ford Hlth Syst, Detroit, MI USA
Moon, J:
Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
Baumgarten, A:
Ctr Infectiol, Atlanta, GA USA
Workowski, K:
Emory Univ, Sch Med, Atlanta, GA 30322 USA
|